» Articles » PMID: 38733445

Insight into the Pathophysiological Advances and Molecular Mechanisms Underlying Cerebral Stroke: Current Status

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2024 May 11
PMID 38733445
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular pathways involved in cerebral stroke are diverse. The major pathophysiological events that are observed in stroke comprises of excitotoxicity, oxidative stress, mitochondrial damage, endoplasmic reticulum stress, cellular acidosis, blood-brain barrier disruption, neuronal swelling and neuronal network mutilation. Various biomolecules are involved in these pathways and several major proteins are upregulated and/or suppressed following stroke. Different types of receptors, ion channels and transporters are activated. Fluctuations in levels of various ions and neurotransmitters have been observed. Cells involved in immune responses and various mediators involved in neuro-inflammation get upregulated progressing the pathogenesis of the disease. Despite of enormity of the problem, there is not a single therapy that can limit infarction and neurological disability due to stroke. This is because of poor understanding of the complex interplay between these pathophysiological processes. This review focuses upon the past to present research on pathophysiological events that are involved in stroke and various factors that are leading to neuronal death following cerebral stroke. This will pave a way to researchers for developing new potent therapeutics that can aid in the treatment of cerebral stroke.

Citing Articles

Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes.

Yadav V, Gupta R, Assiri A, Uddin J, Ishaqui A, Kumar P J Funct Biomater. 2025; 16(1).

PMID: 39852564 PMC: 11766075. DOI: 10.3390/jfb16010008.


MAM-mediated mitophagy and endoplasmic reticulum stress: the hidden regulators of ischemic stroke.

Jia Z, Li H, Xu K, Li R, Yang S, Chen L Front Cell Neurosci. 2024; 18:1470144.

PMID: 39640236 PMC: 11617170. DOI: 10.3389/fncel.2024.1470144.


Silencing lncRNA GABPB1-AS1 alleviates cerebral ischemia reperfusion injury through the miR-641/NUCKS1 axis.

Yu S, Zhou Z, Liang Z, Ruan C, Bai L, Pi Y Am J Transl Res. 2024; 16(7):2963-2972.

PMID: 39114718 PMC: 11301495. DOI: 10.62347/EAGK7098.

References
1.
Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Blaha M . Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014; 129(3):399-410. DOI: 10.1161/01.cir.0000442015.53336.12. View

2.
Jackevicius C, Li P, Tu J . Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008; 117(8):1028-36. DOI: 10.1161/CIRCULATIONAHA.107.706820. View

3.
Donahue M, Achten E, Cogswell P, de Leeuw F, Derdeyn C, Dijkhuizen R . Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease. J Cereb Blood Flow Metab. 2017; 38(9):1391-1417. PMC: 6125970. DOI: 10.1177/0271678X17721830. View

4.
Dhapola R, Hota S, Sarma P, Bhattacharyya A, Medhi B, Reddy D . Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease. Inflammopharmacology. 2021; 29(6):1669-1681. PMC: 8608577. DOI: 10.1007/s10787-021-00889-6. View

5.
Thakur S, Dhapola R, Sarma P, Medhi B, Reddy D . Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics. Inflammation. 2022; 46(1):1-17. DOI: 10.1007/s10753-022-01721-1. View